ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOF
The disclosure relates to methods for treating atopic dermatitis with an antibody that binds to stem cell factor 248 (SCF248).
1 . A method for treating atopic dermatitis in a human patient with atopic dermatitis, comprising administering to the human patient a therapeutically effective dose of a full length anti-stem cell factor 248 (anti-SCF248) antibody, wherein the full length anti-SCF248 antibody comprises two heavy chains each having the amino acid sequence of SEQ ID NO: 42 and two light chains each having the amino acid sequence of SEQ ID NO: 49; wherein the therapeutically effective dose is from 10 mg to 600 mg regardless of the human patient's body weight, and wherein treating is reducing or eliminating itching or a skin rash in the human patient.
2 - 105 . (canceled)